EVARREST™ Fibrin Sealant Patch Post-Market Study

Completed · Phase 4

Conditions studied: Hemorrhage, Soft Tissue Bleeding

In brief

The objective of this study is to evaluate the clinical utility of EVARREST™ Fibrin Sealant Patch (Fibrin Pad) as an adjunct to hemostasis in soft tissue bleeding during intra-abdominal (stomach area), retroperitoneal (hip and stomach area), pelvic (hip area) and non-cardiac thoracic (chest area) surgery.

Key facts

Study ID
NCT01902459
Run by
Ethicon, Inc.
People needed
150
Starts
2013-07-01
Expected to finish
2015-09-01
Last updated by the study team
2018-01-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.